{
  "question_id": "SCI-002",
  "question": "How do CRISPR-Cas systems work and what are the key advances in gene editing technology?",
  "expert_sources": [
    {
      "title": "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity",
      "authors": ["Jinek et al."],
      "venue": "Science 2012",
      "url": "https://doi.org/10.1126/science.1225829",
      "relevance": "Original CRISPR-Cas9 gene editing paper"
    },
    {
      "title": "Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage",
      "authors": ["Gaudelli et al."],
      "venue": "Nature 2017",
      "url": "https://doi.org/10.1038/nature24644",
      "relevance": "Adenine base editor development"
    },
    {
      "title": "Search-and-replace genome editing without double-strand breaks or donor DNA",
      "authors": ["Anzalone et al."],
      "venue": "Nature 2019",
      "url": "https://doi.org/10.1038/s41586-019-1711-4",
      "relevance": "Prime editing introduction"
    },
    {
      "title": "Off-target Effects in CRISPR/Cas9-mediated Genome Engineering",
      "authors": ["Zhang et al."],
      "venue": "Molecular Therapy 2015",
      "url": "https://doi.org/10.1016/j.omtn.2015.07.005",
      "relevance": "Off-target effect analysis"
    },
    {
      "title": "CRISPR-Cas9 Therapeutics: Progress and Future Prospects",
      "authors": ["Various clinical reviews"],
      "venue": "Multiple journals",
      "url": "Various",
      "relevance": "Clinical applications overview"
    }
  ],
  "key_findings": [
    {
      "finding": "CRISPR-Cas9 creates double-strand breaks at guide RNA-specified locations",
      "importance": "critical",
      "sources": ["Jinek et al. 2012"]
    },
    {
      "finding": "Base editors enable C-to-T and A-to-G conversions without double-strand breaks",
      "importance": "critical",
      "sources": ["Gaudelli et al. 2017"]
    },
    {
      "finding": "Prime editing enables any small edit without DSBs or donor DNA templates",
      "importance": "critical",
      "sources": ["Anzalone et al. 2019"]
    },
    {
      "finding": "Off-target effects occur when guide RNA matches unintended genomic sites",
      "importance": "critical",
      "sources": ["Zhang et al. 2015"]
    },
    {
      "finding": "High-fidelity Cas9 variants reduce off-target editing",
      "importance": "high",
      "sources": ["Various Cas9 engineering papers"]
    },
    {
      "finding": "FDA approved first CRISPR therapy (Casgevy for sickle cell) in 2023",
      "importance": "high",
      "sources": ["FDA approvals"]
    }
  ],
  "known_counterarguments": [
    {
      "argument": "CRISPR may cause undetected large deletions or rearrangements",
      "validity": "Valid concern, improved detection methods being developed",
      "sources": ["Kosicki et al. 2018"]
    },
    {
      "argument": "Delivery to target tissues remains a major challenge",
      "validity": "True, especially for in vivo applications",
      "sources": ["Clinical development challenges"]
    },
    {
      "argument": "Immune responses to Cas proteins may limit repeated use",
      "validity": "Valid for some applications, being addressed",
      "sources": ["Immunogenicity studies"]
    }
  ],
  "confidence_bounds": {
    "overall_confidence": 0.92,
    "areas_of_uncertainty": [
      "Long-term safety of edited cells",
      "Optimal delivery methods for different tissues",
      "Unintended consequences of large-scale editing"
    ],
    "last_updated": "2024-01"
  },
  "evaluation_rubric": {
    "must_include": [
      "CRISPR-Cas9 mechanism (guide RNA, DSB)",
      "Base editing or prime editing advances",
      "Off-target effects as key concern",
      "At least one clinical application"
    ],
    "should_include": [
      "PAM sequence requirement",
      "HDR vs NHEJ repair pathways",
      "High-fidelity variants"
    ],
    "bonus_points": [
      "Comparison of Cas9, base editors, prime editors",
      "Specific approved therapies",
      "Delivery challenges"
    ]
  }
}
